Alector Prices Stock Sale At $2.05 A Share, Aiming For $75.03 Million In Gross Proceeds

The $2.05 price sits about 7.3% above the October 15 close, and Alector says it will fund research, manufacturing and possible deals.

Share
Alector Prices Stock Sale At $2.05 A Share, Aiming For $75.03 Million In Gross Proceeds

Alector priced an underwritten sale of 36,600,000 shares of common stock at $2.05 each, an 8-K filed Friday shows, for expected gross proceeds of $75,030,000.00. That is before underwriting discounts, commissions and other offering expenses.

What the filing and release say

Every share in the offering is being sold by Alector itself, not by existing holders, according to the 8-K. The company signed the underwriting agreement on October 15 with Morgan Stanley & Co. LLC and BTIG, LLC, which are the joint lead book-running managers.

The press release says the $2.05 price is a premium of approximately 7.3% over the October 15 closing price. The financing includes new and existing investors, among them TCGX, BVF Partners, ADAR1 Capital Management and Deep Track Capital.

The sale runs off a shelf registration statement, a filing that lets a company sell stock later, that the SEC had already declared effective.

What it changes for holders

Alector is issuing 36,600,000 new shares, so the share count you own a slice of grows by that amount once the deal closes.

The company plans to spend the net proceeds on general corporate purposes. Those may include research, development and manufacturing of its product candidates, working capital and capital expenditures. They may also cover acquisitions of, or strategic transactions in, complementary products, technologies or businesses.

Alector describes itself as a biotechnology company working on therapies for neurodegeneration, with programs aimed at diseases including Alzheimer's and Parkinson's.

Price and timing

Alector shares closed at $1.84 on Friday, down 3.66% on the session, before the filing was accepted at 4:47 p.m. ET. The offering price compares with that figure and with the October 15 close the company cites for its premium.

The company expects the offering to close on or about October 19, subject to customary closing conditions. The release cautions that there is no assurance the offering will be completed.

Closing is expected on or about October 19, at which point the $75,030,000.00 in gross proceeds, before costs, is due to reach Alector.

Sources

More on Alector

All Alector (ALEC) coverage →